Bioresorbable mesh fully resorbs into the body in ~9 weeks
• Requires no adjustment to
standard surgical techniques during replacement or revision procedures.
Identical antibiotic combination as original AIGISRX Envelope
• It contains the same locally released antimicrobial agent combination— Rifampin and Minocycline—to help reduce CIED infection following implantation.1-6
Multiple studies support clinical efficacy
• Patients at high risk for CIED infection who are implanted with the AIGISRX Envelope had 70% to 100% fewer infections compared to patients without it.7-9
Significantly reduces costs of infection in CIED implants
• Your facility can reduce costs by
as much as $100,000 for every 100 AIGISRX Envelopes used with your high-risk CIED patients.8-12